Safety measures for drug got sidetracked
A Japan pharmaceutical firm's tardiness in taking safety precautions with a drug linked to more than 120 deaths may have been due to concerns that such moves could have hampered the drug's approval
A Japan pharmaceutical firm's tardiness in taking safety precautions with a drug linked to more than 120 deaths may have been due to concerns that such moves could have hampered the drug's approval